|
Contents |
|
|
|
Diagnosis
& Evaluation
|
|
Etiology & Pathogenesis
|
|
Integrative
Medicine
|
|
Overall Management
|
|
Psychosocial
Aspects
|
|
Treatment
|
|
|
|
|
Diagnosis
& Evaluation
|
|
|
| |
Kumar
AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA
Malignant
gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced
necrosis of the brain after treatment
Radiology. 2000 Nov;217(2):377-84
|
|
|
Etiology & Pathogenesis
|
|
|
|
Maher EA,
Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA
Malignant
glioma: genetics and biology of a grave matter
Genes Dev. 2001 Jun 1;15(11):1311-33
|
|
|
|
|
|
Integrative
Medicine
|
|
|
|
Evan
Ross, LAc
Case Report: A Favorable
Outcome for an Unconventional Treatment of Glioblastoma Multiforme
Summer 2003 issue of Neurosciences
Report
|
|
Inskip
PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine
HA, Black PM, Loeffler JS, Linet MS
Cellular-telephone
use and brain tumors
N Engl J Med. 2001 Jan 11;344(2):79-86
|
|
|
Overall Management
|
|
|
|
Bauman
GS, Cairncross JG
Multidisciplinary
management of adult anaplastic oligodendrogliomas and anaplastic mixed
oligo-astrocytomas
Semin Radiat Oncol. 2001 Apr;11(2):170-80
|
|
Victor
Levin, MD
Primary CNS Tumors
American
Society of Clinical Oncology, www.asco.org, Posted 07.17.2002
|
|
Levin VA
Chemotherapy
for brain tumors of astrocytic and oligodendroglial lineage: the past decade and
where we are heading
Neuro-oncol. 1999 Jan;1(1):69-80
|
|
Wong
ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung
WK
Outcomes
and prognostic factors in recurrent glioma patients enrolled onto phase II
clinical trials
J Clin Oncol. 1999 Aug;17(8):2572
|
|
|
Psychosocial
Aspects
|
|
|
|
|
Meyers CA, Weitzner MA, Valentine AD,
Levin VA
Methylphenidate
therapy improves cognition, mood, and function of brain tumor patients
J Clin Oncol. 1998 Jul;16(7):2522-7
|
|
Scheibel RS,
Meyers CA, Levin VA.
Cognitive
dysfunction following surgery for intracerebral glioma: influence of
histopathology, lesion location, and treatment
J Neurooncol. 1996 Oct;30(1):61-9
|
|
|
Treatment
|
|
|
|
Barker
FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB
Survival
and functional status after resection of recurrent glioblastoma multiforme
Neurosurgery. 1998 Apr;42(4):709-20
|
|
Constantini
S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ
Radical
excision of intramedullary spinal cord tumors: surgical morbidity and
long-term follow-up evaluation in 164 children and young adults
J Neurosurg. 2000 Oct;93(2 Suppl):183-93
|
|
Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF,
Martin L, Curran WJ Jr
White
matter changes are correlated significantly with radiation dose.
Observations from a randomized dose-escalation trial for malignant glioma
(Radiation Therapy Oncology Group 83-02)
Cancer. 1994 Nov
15;74(10):2828-35
|
|
Curran WJ
Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K,
Fischbach AJ, Yakar D, Schwade JG, et al.
Survival
comparison of radiosurgery-eligible and -ineligible malignant glioma patients
treated with hyperfractionated radiation therapy and carmustine: a report of
Radiation Therapy Oncology Group 83-02
J Clin Oncol. 1993 May;11(5):857-62
|
|
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F,
Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller
D, Sawaya R
A
multivariate analysis of 416 patients with glioblastoma multiforme:
prognosis, extent of resection, and survival
J Neurosurg. 2001
Aug;95(2):190-8
|
|
Levin
VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds
N, Woo S, Rodriguez L, et al
Phase
II study of accelerated fractionation radiation therapy with carboplatin
followed by vincristine chemotherapy for the treatment of glioblastoma
multiforme
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64
|
|
Nagendra
Ningaraj, PhD, and Asha Das, MD
Riluzole:
A Potent Anti-Brain Tumor Agent?
Summer
2003 issue of Neurosciences Report
|
|
Prados
MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R,
Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr
A
phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and
vincristine (PCV) with or without BUdR for the treatment of anaplastic
astrocytoma: a preliminary report of RTOG 9404
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15
|
|
Prados MD,
Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE,
Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA,
Gutin PH, Phillips TL, Wilson CB
Radiation
therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU
for the treatment of primary malignant brain tumors
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):57-63
|
|
Wisoff JH, Boyett JM, Berger MS, Brant C, Li H, Yates AJ,
McGuire-Cullen P, Turski PA, Sutton LN, Allen JC, Packer RJ, Finlay JL
Current
neurosurgical management and the impact of the extent of resection in the
treatment of malignant gliomas of childhood: a report of the Children's
Cancer Group trial no. CCG-945
J Neurosurg. 1998
Jul;89(1):52-9
|
bottom
|